KAT14 and cervical carcinoma: We further observed that the CSRP2BP overexpression decreased the sensitivity of cervical cancer cells to cisplatin in a dose-dependent manner, suggesting the involvement of CSRP2BP in the chemotherapy resistance of cervical cancer.